Spherical Agglomeration of Naproxan by Solvent Change Method

Authors

  • Parthasarathi Keshavarao Kulkarni Department of Pharmaceutics, J.S.S College of Pharmacy, S.S Nagar, Mysore
  • Mudit Dixit Department of Pharmaceutics, J.S.S College of Pharmacy, S.S Nagar, Mysore
  • Achin Jain Department of Pharmaceutics, J.S.S College of Pharmacy, S.S Nagar, Mysore

DOI:

https://doi.org/10.3329/sjps.v4i1.8860

Keywords:

Spherical agglomerates, Naproxen, Crystallinity, Dissolution.

Abstract

Naproxen, an anti-inflammatory drug, exhibits poor water solubility and flow properties. Spherical agglomerates were prepared by solvent change method. Solvent composition for spherical agglomeration was determined by constructing ternary diagram. Crystallization medium used for spherical agglomerates of naproxen consisted of tetra-hydro-furan (good solvent); water (poor solvent); isopropyl acetate (bridging liquid) in the ratio of 29:61:10, respectively. Spherical agglomerates were characterized by differential scanning calorimetry, infrared spectroscopy, X-ray diffractometry and scanning electron microscopy. Micromeritic and dissolution behavior studies were carried out. Process variables such as amount of bridging liquid, stirring time and duration of stirring were optimized. Dissolution profile of the spherical agglomerates was compared with pure sample and recrystallized sample. Spherical agglomerates exhibited decreased crystallinity and improved micromeritic properties. The dissolution of the spherical agglomerates was not improved compared with pure sample because the dissolution of naproxen dependent on particle size or surface area.  

Key words: Spherical agglomerates; Naproxen; Crystallinity; Dissolution.

DOI: http://dx.doi.org/10.3329/sjps.v4i1.8860

SJPS 2011; 4(1): 1-8

Downloads

Download data is not yet available.
Abstract
111
PDF
359

Downloads

How to Cite

Kulkarni, P. K., Dixit, M., & Jain, A. (2011). Spherical Agglomeration of Naproxan by Solvent Change Method. Stamford Journal of Pharmaceutical Sciences, 4(1), 1–8. https://doi.org/10.3329/sjps.v4i1.8860

Issue

Vol. 4 No. 1 (2011)

Section

Research Articles

License

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.